Skip to content
TubeRank.
Get app
HIMS

The call, on record

HIMS bullish call

Recorded from Asymmetric Investing by Travis Hoium’s public commentary. Review the evidence behind the call and its outcome.
HIMSBullNot scored
Asymmetric Investing by Travis HoiumAsymmetric Investing by Travis Hoium
AI-extracted record · awaiting moderator review. The quote is source evidence; the structured call and thesis are TubeRank’s interpretation.
Quoted text as recorded“I think we could see this past 4 million, maybe even 5 million subscribers in 2027.”

Our interpretation

Source published
Jul 29, 2026
Timeframe
in 2027
Extracted deadline
Dec 31, 2027
Interpreted confidence
low
Specificity
vague

Why this call is unscored

Status
Not scored
Notes
There is no numerical target that can be objectively scored.

How outcomes are decided · Report an error

Email me when HIMS calls resolve

When a tracked HIMS call is scored — hit, miss or partial — we’ll email you the result. No account needed.

Used only for these updates. Privacy

Follow Asymmetric Investing by Travis Hoium in the iPhone appEvery HIMS call on file

Evidence and source

Hims & Hers Stock ALERT! -- Everything You Need to Know
Published on Jul 29, 2026Open on YouTube

Our summary of the thesis

Bullish

Structured interpretation of the video, not a verbatim quotation. Check the source for conditions, emphasis and context.

Travis argues the FTC lawsuit against Hims & Hers is a short-term headline, not a structural threat, and actually signals that the company is winning against incumbent pharma by disrupting the industry. He views the stock's 13% drop as a potential buying opportunity similar to the earlier Novo Nordisk lawsuit dip, citing the company's strong subscriber growth, transparent pricing, and small fines relative to its $2.4 billion revenue base.

Key arguments

  • Big pharma is terrified of Hims & Hers becoming the 'front door' to healthcare, as shown by the peptide hearing and now the FTC lawsuit.
  • The specific FTC allegations (billing before provider visit, difficult cancellation, data sharing) are not serious issues based on his personal use of the app.
  • Comparable FTC fines against other digital health companies have ranged from $1.5 million to $10 million, which would be immaterial against Hims & Hers' $2.4 billion in revenue.
  • The earlier Novo Nordisk lawsuit caused a similar stock drop that turned out to be a great buying opportunity.
  • Regulatory and legal pushback from incumbents is itself evidence that Hims & Hers is winning market share, similar to taxis fighting Uber.
  • Hims & Hers is the biggest position in his Asymmetric Investing portfolio.

Counter-arguments acknowledged

  • There could be a settlement or fine resulting from the lawsuit.
  • The company may need to change some business practices as a result of the FTC action.
  • The stock dropped over 10-13% on the news.

Hedges and caveats (from the video)

  • FTC lawsuit involves three substantive claims: data sharing practices, charging before provider meetings, and difficult cancellation processes
  • Investigation disclosed years ago with $15 million charge-off already taken
  • Short-term stock volatility expected but characterized as noise rather than structural risk
  • Comparison drawn to previous Nova Nordisk lawsuit that initially caused stock to crater but proved to be buying opportunity

About this record

Not yet reviewed by a moderator

AI-extracted record. A quote, summary and outcome each need their own context. Moderator review does not certify investment performance.

Source published
Jul 29, 2026, 7:46 PM UTC
First recorded by TubeRank
Jul 29, 2026, 8:17 PM UTC
Record last updated
Oct 6, 2026, 6:32 AM UTC
Moderator review recorded
Not recorded
Transcript provenance
YouTube captions (manual or automatic)
Recorded analysis processor/source label
claude-sonnet-5
This can identify a workflow rather than an exact AI model version.
Extraction pipeline version
v1.0.0
Outcome methodology version
2026-10-06.5
Outcome reason code
missing_target
Publication is when the video was released; recording is when TubeRank added this call. They are not interchangeable. Legacy records can lack version and observation metadata. Dates are shown in UTC.
Recent record changes 4 shown

  1. Oct 6, 2026, 6:32 AM UTC

    corrected

    Outcome methodology version

    Before2026-10-06.4

    After2026-10-06.5

  2. Oct 6, 2026, 5:14 AM UTC

    corrected

    Outcome methodology version

    Before2026-10-06.2

    After2026-10-06.4

  3. Oct 6, 2026, 4:00 AM UTC

    corrected

    Outcome methodology version

    Before2026-10-06.1

    After2026-10-06.2

  4. Oct 6, 2026, 3:27 AM UTC

    missing target

    Outcome methodology version

    BeforeNot recorded

    After2026-10-06.1

    Recorded outcome date

    BeforeNot recorded

    After2026-10-06

    Outcome explanation

    BeforeNot recorded

    AfterThere is no numerical target that can be objectively scored.

    Outcome reason

    BeforeNot recorded

    AfterMissing target

Showing up to 20 recent changes. The complete feed has 5 recorded events for this call, including its initial entry. Read the full paginated history (JSON); follow nextCursor while hasMore is true.

Methodology and limitationsReport a correction
Stored outcome evidence
Stored reference price
Not recorded
Not recorded · provider not recorded
Target as extracted
Not recorded
Stated deadline as extracted
Dec 31, 2027
Recorded outcome date
Oct 6, 2026
Outcome price observation
Not recorded
Not recorded · provider not recorded

Stored explanation

There is no numerical target that can be objectively scored.

Missing timestamps, providers and versions are historical gaps. Stored observations can include daily closes; they do not show every intraday touch or prove an executable trade. Read the methodology.

Why we interpreted the confidence this way

Hedge words 'could' and 'maybe' significantly reduce certainty despite a specific timeframe and numbers being given.

View full video analysisView YouTuber profile